168 related articles for article (PubMed ID: 2136827)
21. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.
Coleman RE
Oncology (Williston Park); 1991 Aug; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153
[TBL] [Abstract][Full Text] [Related]
22. Treatment of skeletal disease in breast cancer: a controlled clodronate trial.
Elomaa I; Blomqvist C; Porkka L; Lamberg-Allardt C; Borgström GH
Bone; 1987; 8 Suppl 1():S53-6. PubMed ID: 2961355
[TBL] [Abstract][Full Text] [Related]
23. A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy.
Kawada K; Minami H; Okabe K; Watanabe T; Inoue K; Sawamura M; Yagi Y; Sasaki T; Takashima S
Jpn J Clin Oncol; 2005 Jan; 35(1):28-33. PubMed ID: 15681601
[TBL] [Abstract][Full Text] [Related]
24. Hypercalcemic complication in patients with oral squamous cell carcinoma.
Iwase M; Takemi T; Manabe M; Nagumo M
Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
[TBL] [Abstract][Full Text] [Related]
25. [Hypercalcemia in bronchogenic carcinoma].
Zatloukal P; Macholda F; Mĕricka O; Voslárová Z; Zich M; Bilyk I
Sb Lek; 1989 Mar; 91(2-3):87-91. PubMed ID: 2749169
[TBL] [Abstract][Full Text] [Related]
26. Results of a randomized study of clodronate in treating cancer-related hypercalcemia.
Peck WA
Arch Intern Med; 1987 Nov; 147(11):2056-7. PubMed ID: 2960292
[No Abstract] [Full Text] [Related]
27. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
Tubiana-Hulin M; Beuzeboc P; Mauriac L; Barbet N; Frenay M; Monnier A; Pion JM; Switsers O; Misset JL; Assadourian S; Bessa E
Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
[TBL] [Abstract][Full Text] [Related]
28. [Clodronate].
Franzosi MG; Devoto MA
Medicina (Firenze); 1988; 8(1):105-9. PubMed ID: 2976107
[No Abstract] [Full Text] [Related]
29. [Value of Clodronate in the treatment of bone metastasis].
Pouillart P; Beuzeboc P
Bull Cancer; 1991; 78(8):737-41. PubMed ID: 1834287
[TBL] [Abstract][Full Text] [Related]
30. [On the pathology and clinical picture of tumor endocarditis].
Stosiek P
Dtsch Med Wochenschr; 1969 Apr; 94(17):908-11. PubMed ID: 5778747
[No Abstract] [Full Text] [Related]
31. Effect of a single infusion of alendronate in malignant hypercalcaemia: dose dependency and comparison with clodronate.
Rizzoli R; Buchs B; Bonjour JP
Int J Cancer; 1992 Mar; 50(5):706-12. PubMed ID: 1531972
[TBL] [Abstract][Full Text] [Related]
32. Primary hyperparathyroidism in paraneoplastic hypercalcaemia.
Drezner MK; Lebovitz HE
Lancet; 1978 May; 1(8072):1004-6. PubMed ID: 76931
[TBL] [Abstract][Full Text] [Related]
33. Clodronate treatment in patients with malignancy-associated hypercalcemia.
Rastad J; Benson L; Johansson H; Knuutila M; Pettersson B; Wallfelt C; Akerström G; Ljunghall S
Acta Med Scand; 1987; 221(5):489-94. PubMed ID: 2955674
[TBL] [Abstract][Full Text] [Related]
34. Immobilisation hypercalcaemia in adults and treatment with clodronate.
Yates AJ; Jones TH; Mundy KI; Hague RV; Brown CB; Guilland-Cumming D; Kanis JA
Br Med J (Clin Res Ed); 1984 Oct; 289(6452):1111-2. PubMed ID: 6237713
[No Abstract] [Full Text] [Related]
35. Use of diphosphonates in hypercalcaemia due to malignancy.
Kanis JA; McCloskey EV; Paterson AH
Lancet; 1990 Jan; 335(8682):170-1. PubMed ID: 1967461
[No Abstract] [Full Text] [Related]
36. Clodronate. A randomized study in the treatment of cancer-related hypercalcemia.
Witte RS; Koeller J; Davis TE; Benson AB; Durie BG; Lipton A; Stock JL; Citrin DL; Jacobs TP
Arch Intern Med; 1987 May; 147(5):937-9. PubMed ID: 2953318
[TBL] [Abstract][Full Text] [Related]
37. Clodronate as a single-dose intravenous infusion effectively provides short-term correction of malignant hypercalcemia.
Atula ST; Tähtelä RK; Nevalainen JI; Pylkkänen LH
Acta Oncol; 2003; 42(7):735-40. PubMed ID: 14690159
[TBL] [Abstract][Full Text] [Related]
38. Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases--a prospective randomised placebo-controlled multicentre study.
Rotstein S; Glas U; Eriksson M; Pfeiffer P; Hansen J; Söderqvist J; Bandmann U; Strid S
Eur J Cancer; 1992; 28A(4-5):890-3. PubMed ID: 1388038
[TBL] [Abstract][Full Text] [Related]
39. Use of bisphosphonates in hypercalcaemia due to malignancy.
Ralston SH; Gallacher SJ; Patel U; Fraser WD; Dryburgh FJ; Boyle IT
Lancet; 1990 Mar; 335(8691):737. PubMed ID: 1969100
[No Abstract] [Full Text] [Related]
40. Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?
Shah S; Hardy J; Rees E; Ling J; Gwilliam B; Davis C; Broadley K; A'Hern R
Br J Cancer; 2002 Apr; 86(8):1235-7. PubMed ID: 11953878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
